Ads
related to: kesimpta approval- Copay Program
Explore Important Financial And
Copay Information.
- Financial Support
Understand Financial & Insurance
Support For Your Treatment.
- VUMERITY® Support Program
Join The Support Program To Receive
Tips, Tools And Assistance.
- Resources for Care
Partners. Explore
RMS Articles, Tools & Advice.
- Another Treatment Option
Are You Ready To Switch? Visit
The VUMERITY® Site To Learn More.
- Staying On Track
Download the myVUMERITY™ App To
Stay On Track With Your Treatment.
- Copay Program
Search results
Novartis (NVS) Q2 Earnings & Revenues Top, Guidance Raised
Zacks via Yahoo Finance· 10 months agoSwiss pharma giant Novartis AG NVS reported strong second-quarter 2023 results and shares are...
Novartis (NVS) Tops Q3 Earnings, Ups Operating Income View
Zacks via Yahoo Finance· 7 months agoSwiss pharma giant Novartis AG NVS reported strong sales from key drugs in third-quarter 2023 and...
Novartis' (NVS) Oncology Drugs Get Approval for Label Expansion
Zacks via Yahoo Finance· 2 years agoNovartis NVS has announced that the FDA granted accelerated approval to the combination of Tafinlar...
Novartis (NVS) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Novartis (NYSE: NVS) Q2 2022 Earnings Call Jul 19, 2022, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Novartis (NVS) Entresto Patent Faces Setback, Stock Down
Zacks via Yahoo Finance· 11 months agoNovartis NVS recently received an unfavorable ruling from the U.S. District Court for the District...
Novartis (NVS) Gets CHMP Positive Opinion for Entresto Approval
Zacks via Yahoo Finance· 1 year agoNovartis NVS announced that its cardiovascular drug Entresto (sacubitril/valsartan) has received a...
2 Biotech Stocks That Could Make You Richer
Motley Fool· 1 year agoGrowing one's wealth in the stock market is simple, at least in theory. All that's needed are time, the right investments, and the patience to hold...
Pharma Stock Roundup: SNY, MRK, NVS Report Q3 Earnings, FDA Okays PFE, LLY Products
Zacks via Yahoo Finance· 7 months agoThis week, Merck MRK, Sanofi SNY and Novartis NVS announced their third-quarter results. The FDA...
Pharma Stock Roundup: NVS, MRK Report Q3 Earnings JNJ's Tecvayli Gets FDA Nod
Zacks via Yahoo Finance· 2 years agoThis week, Novartis NVS and Merck MRK announced their third-quarter earnings. The FDA approved J&J’s...
Why Novartis Stock Is Trading Higher Today
Benzinga via Yahoo Finance· 1 year agoNovartis AG (NYSE: NVS) has reported Q1 FY23 core EPS of $1.71 compared to $1.46 a year ago, beating the consensus of $1.55. Net sales were $12.95...
Ads
related to: kesimpta approval